| 23rd Jan 2023 12:20 pm |
RNS |
Issue of Equity and Total Voting Rights |
| 17th Jan 2023 2:05 pm |
RNS |
Second Price Monitoring Extn |
| 17th Jan 2023 2:00 pm |
RNS |
Price Monitoring Extension |
| 17th Jan 2023 11:05 am |
RNS |
Second Price Monitoring Extn |
| 17th Jan 2023 11:00 am |
RNS |
Price Monitoring Extension |
| 17th Jan 2023 9:05 am |
RNS |
Second Price Monitoring Extn |
| 17th Jan 2023 9:00 am |
RNS |
Price Monitoring Extension |
| 17th Jan 2023 7:00 am |
RNS |
Successful Completion of Fourth Dose Escalation |
| 16th Jan 2023 10:15 am |
RNS |
Block Listing Application to AIM |
| 19th Dec 2022 7:00 am |
RNS |
Avacta to Host Therapeutics Division Science Day |
| 8th Nov 2022 7:01 am |
RNS |
Director/PDMR Shareholding |
| 8th Nov 2022 7:00 am |
RNS |
Result of the Open Offer |
| 31st Oct 2022 1:32 pm |
RNS |
Avacta to Present at Theranostics FAP Summit |
| 31st Oct 2022 11:05 am |
RNS |
Second Price Monitoring Extn |
| 31st Oct 2022 11:00 am |
RNS |
Price Monitoring Extension |
| 28th Oct 2022 7:00 am |
RNS |
Block Listing Six Monthly Return |
| 20th Oct 2022 8:01 am |
RNS |
Director/PDMR Shareholding |
| 20th Oct 2022 8:01 am |
RNS |
Admission of the Company’s Ordinary Shares |
| 20th Oct 2022 7:00 am |
RNS |
Posting of the Company’s Open Offer Circular |
| 18th Oct 2022 11:49 am |
RNS |
Result of Placing |
| 18th Oct 2022 9:16 am |
RNS |
Private CB and ABB Launch |
| 18th Oct 2022 9:14 am |
RNS |
Proposed acquisition of Launch Diagnostics |
| 29th Sep 2022 7:00 am |
RNS |
Interim Results for the Period Ended 30 June 2022 |
| 26th Sep 2022 7:00 am |
RNS |
Notice of Results |
| 5th Sep 2022 7:00 am |
RNS |
AVA6000 receives Orphan Drug Designation from FDA |
| 1st Sep 2022 7:00 am |
RNS |
Phase I study of AVA6000 advances to fourth cohort |
| 21st Jul 2022 7:00 am |
RNS |
AffyXell successfully completes funding round |
| 30th Jun 2022 7:00 am |
RNS |
LG Chem renews license triggers payment to Avacta |
| 29th Jun 2022 9:05 am |
RNS |
Second Price Monitoring Extn |
| 29th Jun 2022 9:00 am |
RNS |
Price Monitoring Extension |
| 29th Jun 2022 7:00 am |
RNS |
Second dose escalation in phase 1 trial of AVA6000 |
| 23rd Jun 2022 4:41 pm |
RNS |
Second Price Monitoring Extn |
| 23rd Jun 2022 4:36 pm |
RNS |
Price Monitoring Extension |
| 23rd Jun 2022 4:27 pm |
RNS |
Result of Annual General Meeting |
| 16th Jun 2022 4:41 pm |
RNS |
Second Price Monitoring Extn |
| 16th Jun 2022 4:36 pm |
RNS |
Price Monitoring Extension |
| 31st May 2022 7:00 am |
RNS |
Posting of Annual Report and Notice of AGM |
| 16th May 2022 12:00 pm |
RNS |
AffyXell expands partnership with GenScript ProBio |
| 11th May 2022 7:00 am |
RNS |
London Therapeutics headquarters established |
| 6th May 2022 7:00 am |
RNS |
Block Listing Application to AIM (update) |
